GenMont Biotech

GenMont Biotech Net Margin

The Net Profit Margin of GenMont Biotech (3164.TW) as of Oct 21, 2026 is 14.26 %. In the previous year, Net Profit Margin was 14.86 % — a change of -4.04% (lower).

Net Margin

14.26 %

YoY

-4.04%

Last updated:

Net Profit Margin of GenMont Biotech is 2025 14.26 % . Net Profit Margin of GenMont Biotech was 2024 14.86 % . It decreases by -4.04% lower compared to the previous year.

For GenMont Biotech, the net margin of 14.3% is down versus 26.4% a few years ago.

The GenMont Biotech Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
38.87 TWD
Jan 1, 2019
16.59 TWD
Jan 1, 2020
18.72 TWD
Jan 1, 2021
26.44 TWD
Jan 1, 2022
15.46 TWD
Jan 1, 2023
10.37 TWD
Jan 1, 2024
14.86 TWD
Jan 1, 2025
14.26 TWD
The GenMont Biotech Net Margin history
YEARNet MarginYoY
14.26 %-4.04%
14.86 %+43.20%
10.37 %-32.90%
15.46 %-41.52%
26.44 %+41.20%
18.72 %+12.84%
16.59 %-57.31%
38.87 %+224.47%
11.98 %-127.46%
-43.63 %+137.99%
-18.33 %-73.20%
-68.40 %-68,510.04%
0.10 %-20.22%
0.13 %-5.99%
0.13 %-53.50%
0.29 %+17.32%
0.24 %+42.27%
0.17 %-24.25%
0.23 %+256.52%
0.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GenMont Biotech Stock analysis

What does GenMont Biotech do? GenMont Biotech Inc. is a biotechnology company based in Tainan, Taiwan, specializing in the research, development, manufacturing, and sale of probiotic supplements. Its products, including various strains of lactobacillus, target immune support against dust allergies and digestive health. The company operates domestically in Taiwan and internationally, having listed on the stock market in 2003. GenMont Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GenMont Biotech stock

Net Profit Margin of GenMont Biotech is 14.26 % in 2025.

Net Profit Margin of GenMont Biotech changed from 14.86 % to 14.26 %, representing a -4.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin GenMont Biotech since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's GenMont Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — GenMont Biotech

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — GenMont Biotech